NEW YORK, April 20 (GenomeWeb News) - Nanogen of San Diego and Toronto-based SynX Pharma said today that the Ontario Superior Court of Justice and SynX shareholders have approved Nanogen's all-stock transaction of SynX, which was originally announced in February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.